Načítá se...
Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic
BACKGROUND: The lack of definitive treatment or preventative options for COVID‐19 led many clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic. Regulators, blood centres and hospitals worldwide worked quickly to get CCP to the bedside. Although response was admirable...
Uloženo v:
| Vydáno v: | Vox Sang |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8250874/ https://ncbi.nlm.nih.gov/pubmed/33772791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vox.13096 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|